1094 Favorable preclinical efficacy and safety profile of AVB-001 a novel IL-2 cell-based immunotherapy that eradicates ovarian cancer in mouse tumor models and supports first in human clinical development

Authors :: Guillaume Carmona
Amanda Nash
Ryan Newman
Jake Schladenhauffen
Maria Jarvis
Samira Aghlara-Fotovat
Sudip Mukherjee
Andrea Hernandez
Andrew Hecht
Peter Rios
Shirin Nouraein
Rahul Sheth
Weiyi Peng
Jose Oberholzer
Amir Jazaeri
Omid Veiseh
Source :: Regular and Young Investigator Award Abstracts.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Tools